Source: Eur Respir J 2005; 26: 637-646
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Bilolikar H., Nam A. R., Rosenthal M., Davies J. C., Henderson D. C., Balfour-Lynn I. M.. Tumour necrosis factor gene polymorphisms and childhood wheezing. Eur Respir J 2005; 26: 637-646

Member's Comments

No comment yet.

Related content which might interest you: Tumour necrosis factor and lymphotoxin A polymorphisms: a relationship with COPD and its progression? Source: Eur Respir J 2007; 29: 8-10 Year: 2007 Cytokines in asthma Source: Eur Respir J 2001; 18: 24S-33S Year: 2001 Vascular endothelial growth factor and tumor necrosis factor gene polymorphisms in Turkish patients with sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 353s Year: 2006 Study of tumor necrosis factor family genes in two phenotypes of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 87s Year: 2002 Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002 Joint effect of obesity and TNFA variability on asthma: two international cohort studies Source: Eur Respir J 2009; 33: 1003-1009 Year: 2009 Mast cell-derived tumour necrosis factor is essential for allergic airway disease Source: Eur Respir J 2008; 31: 773-782 Year: 2008 Tumour necrosis factor gene polymorphisms are associated with COPD Source: Eur Respir J 2008; 31: 1005-1012 Year: 2008 Transforming growth factor-? gene polymorphisms in different phenotypes of sarcoidosis Source: Eur Respir J 2011; 37: 169-175 Year: 2011 Variation in the tumour necrosis factor gene is not associated with susceptibility to COPD Source: Eur Respir J 2007; 30: 810-812 Year: 2007 Tumor necrosis factor-α gene polymorphisms in COPD in a Spanish population Source: Eur Respir J 2005; 26: Suppl. 49, 94s Year: 2005 Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers Source: Eur Respir J 2007; 29: 34-41 Year: 2007 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 TNFA -308G>A in two international population-based cohorts and risk of asthma Source: Eur Respir J 2008; 32: 350-361 Year: 2008 Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial Source: Eur Respir J 2014; 43: 295-298 Year: 2004 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010 Association between polymorphism of tumour necrosis factor α -308 gene promotor and asthma: a meta-analysis Source: Eur Respir J 2006; 28: Suppl. 50, 524s Year: 2006 Tuberculosis and tumor necrosis factor alpha antagonist: Our experience Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006 Genetic polymorphism in the human tumor necrosis factor (TNF) and its association with different clinical types of tuberculosis disease in Peruvian patients Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004